Hikma races to launch generic versions of blockbuster obesity drugs

Discover leading experts on 50,000+ topics for media, events & more.

Connect for media, speaking, expert witness inquiries & more.

Click to connect to media sources & more.

Pharma group looks to take advantage as Wegovy and Ozempic start to go off patent next year

This story appeared on ft.com, 2025-03-09 05:00:17.